Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-79
SponsorKaiser Permanente
About this trial
This study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program.
Eligibility criteria
Qualifiers
Age ≥ 22 years and < 80 years of age
Prediabetes
Insomnia
Regular access to device with internet access
Disqualifiers
BMI > 40 kg/m2
Sleep comorbidities detected in medical record or via medical history
Shift work or significant, externally imposed irregular sleep schedule
moderate to severe OSA by home sleep apnea test as part of trial protocol
Trial design
Treatments tested in this trial
- SHUTi
- Patient Education
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kaiser Permanente
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov